1. Baggio GL, Macedo NF, Merlin JC, Anghebem MI, Santos JCV, Ignácio SA, et al. Inflammatory cytologic alterations in the oral epithelium associated with HIV pre-exposure prophylaxis: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:534-9.

https://doi.org/10.1016/j.oooo.2021.01.010

PMid:33558169 

2. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-99.

https://doi.org/10.1056/NEJMoa1011205

PMid:21091279 PMCid:PMC3079639

3. Dubé MP, Park SY, Ross H, Love TMT, Morris SR, Lee HY. Daily HIV pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate-emtricitabine reduced Streptococcus and increased Erysipelotrichaceae in rectal microbiota. Sci Rep. 2018;8:15212.

https://doi.org/10.1038/s41598-018-33524-6

PMid:30315206 PMCid:PMC6185988

4. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387:53-60.

https://doi.org/10.1016/S0140-6736(15)00056-2

PMid:26364263

5. Sidebottom D, Ekström AM, Strömdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence? BMC Infect Dis. 2018;18:581.

https://doi.org/10.1186/s12879-018-3463-4

PMid:30445925 PMCid:PMC6240194

6. Monteiro Spindola Marins L, Silva Torres T, Luz PM, Moreira RI, Leite IC, Hoagland B, et al. Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study. Int J STD AIDS. 2021;32:1231-41.

https://doi.org/10.1177/09564624211031787

PMid:34311605 

7. Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, et al. Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clin Infect Dis. 2016;62:1172-7.

https://doi.org/10.1093/cid/ciw022

PMid:26797207 PMCid:PMC4826449

8. Drak D, Barratt H, Templeton DJ, O'Connor CC, Gracey DM. Renal function and risk factors for renal disease for patients receiving HIV pre-exposure prophylaxis at an inner metropolitan health service. PLoS One. 2019;14:e0210106.

https://doi.org/10.1371/journal.pone.0210106

PMid:30653509 PMCid:PMC6336260

9. Nickolas TL, Yin MT, Hong T, Mugwanya KK, Branch AD, Heffron R, et al. Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults. Open Forum Infect Dis. 2019;6:ofz338.

https://doi.org/10.1093/ofid/ofz338

PMid:31660332 PMCid:PMC6778426

10. Diz Dios P, Scully C. Antiretroviral therapy: effects on orofacial health and health care. Oral Dis. 2014;20:136-45.

https://doi.org/10.1111/odi.12093

PMid:23530806 

11. Mitchell D, Israr M, Alam S, Dinello D, Kishel J, Jia R, et al. HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium. HIV Med. 2014;15:196-202.

https://doi.org/10.1111/hiv.12100

PMid:24580719 PMCid:PMC3942794

12. Busato IM, Ignácio SA, Brancher JA, Grégio AM, Machado MA, Azevedo-Alanis LR. Impact of xerostomia on the quality of life of adolescents with type 1 diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:376-82.

https://doi.org/10.1016/j.tripleo.2009.05.005

PMid:19716505 

13. Carda C, Mosquera-Lloreda N, Salom L, Gomez de Ferraris ME, Peydró A. Structural and functional salivary disorders in type 2 diabetic patients. Med Oral Patol Oral Cir Bucal. 2006;11:E309-14.

PMid:16816810

14. Kano T, Kanda K. Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum. 2013;40:E79-85.

https://doi.org/10.1188/13.ONF.E79-E85

PMid:23448748 

15. Penteado CAS, Batista TBD, Chaiben CL, Bonacin BG, Ventura TMO, Dionizio A, et al. Salivary protein candidates for biomarkers of oral disorders in alcohol and tobacco dependents. Oral Dis. 2020.

https://doi.org/10.1111/odi.13337

PMid:32237000 

16. Gupta N, Vujicic M, Yarbrough C, Harrison B. Disparities in untreated caries among children and adults in the U.S., 2011-2014. BMC Oral Health. 2018;18:30.

https://doi.org/10.1186/s12903-018-0493-7

PMid:29510696 PMCid:PMC5840689

17. Saes Busato IM, Antoni CC, Calcagnotto T, Ignácio SA, Azevedo-Alanis LR. Salivary flow rate, buffer capacity, and urea concentration in adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2016;29:1359-63.

https://doi.org/10.1515/jpem-2015-0356

PMid:27845883 

18. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533-51.

https://doi.org/10.3109/00016356309011240

PMid:14121956 

19. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand. 1964;22:121-35.

https://doi.org/10.3109/00016356408993968

PMid:14158464 

20. Banderas-Tarabay JA, González-Begné M, Sánchez-Garduño M, Millán-Cortéz E, López-Rodríguez A, Vilchis-Velázquez A. Flujo y concentración de proteínas en saliva total humana [The flow and concentration of proteins in human whole saliva]. Salud Publica Mex. 1997;39:433-41.

https://doi.org/10.1590/S0036-36341997000500006

PMid:9424725 

21. Mandel ID, Wotman S. The salivary secretions in health and disease. J Dent Guid Counc Handicap. 1977;16:3-19.

PMID: 293344

22. Frydrych AM. Dry mouth: Xerostomia and salivary gland hypofunction. Aust Fam Physician. 2016;45:488-92.

PMid:27610431

23. Pushpass RG, Daly B, Kelly C, Proctor G, Carpenter GH. Altered Salivary Flow, Protein Composition, and Rheology Following Taste and TRP Stimulation in Older Adults. Front Physiol. 2019;10:652.

https://doi.org/10.3389/fphys.2019.00652

PMid:31214042 PMCid:PMC6555201

24. Schiffman SS, Zervakis J, Heffron S, Heald AE. Effect of protease inhibitors on the sense of taste. Nutrition. 1999;15:767-72.

https://doi.org/10.1016/S0899-9007(99)00152-5

PMID: 10501290

25. Agha-Hosseini F, Mirzaii-Dizgah I, Mirjalili N. Relationship of unstimulated saliva cortisol level with severity of oral dryness feeling in menopausal women. Aust Dent J. 2011;56:171-4.

https://doi.org/10.1111/j.1834-7819.2011.01320.x

PMid:21623809 

26. Raja JV, Rai P, Khan M, Banu A, Bhuthaiah S. Evaluation of gustatory function in HIV-infected subjects with and without HAART. J Oral Pathol Med. 2013;42:216-21.

https://doi.org/10.1111/jop.12006

PMid:23013048 

27. Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5:S23-30.

https://doi.org/10.2215/CJN.05910809

PMid:20089499 

28. Mingione A, Maruca K, Chiappori F, Pivari F, Brasacchio C, Quirino T, et al. High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity. Biomed Pharmacother. 2018;97:969-74.

https://doi.org/10.1016/j.biopha.2017.11.037

PMid:29136775 

29. Corbetta S, Lania A, Filopanti M, Vicentini L, Ballaré E, Spada A. Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J Clin Endocrinol Metab. 2002;87:2201-5.

https://doi.org/10.1210/jcem.87.5.8492

PMid:11994364 

30. Masiá M, Padilla S, Robledano C, López N, Ramos JM, Gutiérrez F. Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. AIDS Res Hum Retroviruses. 2012;28:242-6.

https://doi.org/10.1089/aid.2011.0052

PMid:21639815